Calculate the following from financial statements from company 1 & 2:

Company 1 Company 2 #3 Current Ratio Current Assets Current Liabilities Result ---> 1 Consolidated Balance Sheets (Dollars in Thousands) Consolidated Statements of Operations and Changes in Net Assets (Dollars in Thousands) December 31 2020 2019 Year Ended December 31 2020 2019 s Consolidated Statements of Cash Flows (Dollars in Thousands) Assets Current assets: Cash and cash equivalents (Note 4) Short-term investments Accounts receivable for medical services Receivable under third-party payor contracts Current portion of contributions receivable Inventories Other current assets Total current assets 94,029 $ 709,158 756,477 7.230 8,777 126,836 180,407 1,882,944 70,725 396,510 709,769 3,993 8,147 130,637 145,762 1,465 543 $ 5,236,783 $ 878,838 8,203 6,123,824 5.400,559 646,000 3.213 6,049,772 Year Ended December 31 2020 2019 Investments 2,141,352 1.989.556 $ Assets limited as to use: Held by insurance subsidiaries Restricted fund investments Other assets limited as to use Total assets limited as to use (18,358) $ 2,797,277 1.671.258 1,223,462 205,760 83,146 108,953 58,017 142,302 49,588 6,339.763 68.246 47,176 10,812 126,234 8,564 2,816,149 1.550,058 1,105,369 195,926 87,721 114,875 63,896 158,647 53,369 6.146,010 63.696 45941 48823 158,460 (215,939) Other long-term assets: Contributions receivable Investments in related parties Right-of-use operating lease assets Goodwill and intangible assets Other long-term assets Total other long-term assets (96,238) Operating revenues: : Patient service revenue Other operating revenue Net assets released from donor restrictions Total operating revenues Expenses: Salaries and benefits Supplies Purchased services Utilities and maintenance Insurance and rent State and local taxes Other operating expenses Depreciation and amortization Interest Total operating expenses Operating loss before non-recurring expenses Non-recurring revenue (expenses) Sale of hospice and home care, net Net risk corridor rebate recovery settlement Restructuring.net Impairment of land, buildings, and equipment Total non-recurring revenue (expenses) Operating loss after non-recurring expenses Nonoperating gains (losses) Investment income Losses on interest rate swaps, net Other nonoperating losses, net Total nonoperating gains (Deficit) excess of revenues over expenses Less amounts attributable to non-controlling interests (Deficit) excess of revenues over expenses attributable to Fairview 10,798 50,070 139,921 87,810 78.560 367,139 10,870 60,376 159,822 90,911 40,066 362,045 142,254 13,706 (2,475) (132,774) 15,940 (15,343) Operating activities (Decrease) increase in net assets Adjustments to reconcile (decrease) increase in net assets to net cash provided by operating activities: Depreciation and amortization Impairment of land, building, and equipment Pension and other postretirement liability adjustments Net realized and unrealized gains on trading investments Change in fair value of interest and basis rate swaps Othernet Changes in assets and liabilities: Accounts receivable for medical services Other current assets Current liabilities Other assets and liabilities, net Net cash provided by operating activities before change in trading and alterative investments Change in trading and alternative investments Net cash provided by operating activities 158,647 122,843 4,119 (234,724) 24.975 (1,517) 53,671 23,458 (4,997) (13,706) 58,426 (15.796) (122,843) (138,639) Land, buildings, and equipment, net Total assets 1,233,167 1,241 310 $ 5,750,856 $ 5,216,914 (157,513) (234,877) (59,880) (34,496) 269,263 275,290 (86,350) 10,693 62,324 9,591 165,713 (22,376) (5,898) 137,439 278,416 (27,845) (2.302) 248,269 December 31 2020 2019 453,127 123,489 576,616 79,165 127,981 207,146 13,392 (20,074) (620) (20,694) (6,397) 6,995 $ (186,151) 366,905 $ 426,541 31,656 23,993 80,666 332,153 340,999 12,677 27,645 30,064 129,043 872,581 Investing activities Purchases of land, buildings, and equipment, net Net proceeds from sale of business Other investing activities Net cash used in investing activities (136,423) 54,045 (1,199 (83,577) Liabilities and net assets Current liabilities: Accounts payable Accrued compensation and benefits Payable under third-party payor contracts Right-of-use operating lease obligations Current maturities of long-term debt Other current liabilities Total current liabilities Other liabilities: Insurance subsidiaries claims reserves Workers' compensation claims reserves Right-of-use operating lease obligations Derivative financial instruments Other long-term liabilities Total other liabilities 31.3.900 (34,531) (220,682) 1,243,661 Year Ended December 31 2020 2019 $ 50,000 (39,614) Pension 34,220 41,930 131,737 38,658 353,492 600,037 32,339 45,195 149,971 82,672 63.345 373,522 (20,694) $ 2,475 4,182 (14,037) 6.995 (4,119) 3.688 6,564 Financing activities Proceeds from issuance of debt Principal payments on long-term debt Payments for defeazance of long-term debt Collateral posted on derivative financial instruments Other financing activities, net Net cash used in financing activities 4,421 (23,405) ( (13,907) (60,067) 2,939 (46,772) 1,873 (31,018) Long-term debt 620 Total liabilities 1,393 323 3,237,021 1,438,618 2,684,721 Net assets without donor restrictions, Fairview: (Deficit) excess of revenues over expenses and other postretirement liability adjustments Other changes, net (Decrease) increase in net assets without donor restrictions, Fairview Net assets without donor restrictions, non-controlling interests: Excess of revenues over expenses Contributions from non-controlling interests Distributions to non-controlling interests and other changes (Decrease) increase in net assets without donor restrictions, non-controlling interests Donor-restricted net assets: Contributions and other changes, net Net assets released from restrictions Decrease in donor-restricted net assets 6,397 2,420 (6.012) (1,672) Increase (decrease) in cash and cash equivalents 446,267 (44,554) (1,052) 2.sos Net assets: Without donor restrictions Fairview Health Services ("Fairview) Non-controlling interests Total net assets without donor restrictions Net assets with donor restrictions Total net assets Total liabilities and net assets Cash, cash equivalents and restricted cash at beginning of year Cash, cash equivalents and restricted cash at end of year (Note 4 349,407 795,674 $ 393,961 349,407 2,411,062 2.425.099 52,347 53,399 2,463,409 2,478,498 50,426 53,695 2,513.835 2,532,193 $ 5,750,856 $ 5,216,914 4,934 (8,203) (3.269) 7,657 (8,463) (805) Supplemental disclosure of noncash investing and financing activities Accruals for purchases of buildings and equipment S 11,316 $ Total (decrease) increase in net assets Net assets at beginning of year Net assets at end of year 3,339 (18,358) 8,564 2,532,193 2.523 629 $ $ $ 2.513,835 $ 2.532 193 Consolidated Statements of Operations and Changes in Net Assets Years ended December 31, 2020 and 2019 (Dollars in thousands) Consolidated Statements of Cash Flows Years ended December 31, 2020 and 2019 Consolidated Balance Sheets 2. (Dollars in thousands) N December 31, 2020 and 2019 2020 2019 Dollars in thousands) 2020 2019 $ 3,904,912 460,701 4,365,613 4,182,456 290,182 4,472,638 $ 132,074 327,057 Assets 2020 2019 $ Current assets Cash and cash equivalents Short-term investments Patient accounts receivable Inventories and supplies Other current assets 698,509 341,563 517,305 89,732 151694 193,703 (4,552) 13,301 2,774,055 1,040,262 184,146 49,354 90,420 78,805 193,011 Revenues Patient service revenue Other operating revenue Total revenues Expenses Salaries and benefits Supplies and services Depreciation and amortization Financing costs State assessments and taxes Utilities and maintenance Other operating expenses Total expenses Operating (loss) income Nonoperating gains (losses): Investment return Loss on interest rate swap agreements Loss on early payoff and refinancing of debt Nonservice periodic pension costs Other Excess of revenues over expenses 2.776,897 1,020,616 193,703 49.851 76,427 77,105 207 228 4.401,827 (36,214) (120,197) (25,042) (2,389) 174,288 471,112 543,509 75,256 124,922 1389,087 2,119,432 166,877 219,542 1275,489 308,965 5,479,392 184,146 (2,969) 16,412 943 (245,270) (14,880) (8,839) 6,597 4,410,053 62,585 327,288 1,798,803 2.276,604 188,517 199,106 1,288,566 303,457 $ 6,055,053 Investments Investments with limited uses Operating lease right-of-use assets, net Land buildings, and equipment, net Other assets Total assets 145,892 (25,008) (2,061) (4,239) (2.222) 76,148 276,426 (25,173) (943) (3,009) (7.882) 302,004 (11,907) 77,209 15,317 e blue sea best (47,949) 64,538 (12,807) 602,462 266,979 $ Cash flows from operating activities: Increase in net assets Adjustments to reconcile increase in net assets to net cash and cash equivalents provided by operating activities: Depreciation and amortization Gain on sale of land, buildings, and equipment Change in fair value of interest rate swaps Loss on early payoff and refinancing of debt Realized and change in unrealized gains on investments, net Restricted contributions including cash for long-lived assets Earnings on unconsolidated entities Distributions received from unconsolidated entities Medicare Advance Payments Changes in assets and liabilities: Change in accounts receivable and other current assets Change in accounts payable and other current liabilities Change in other assets and liabilities Net cash and cash equivalents provided by operating activities Cash flows from investing activities: Proceeds from sales of land, buildings, and equipment Purchases of land, buildings, and equipment Contributions of cash for long-lived assets Purchases of investments Sales of investments Contributions to joint ventures Net cash and cash equivalents used in investing activities Cash flows from financing activities: Restricted contributions, net Change in outstanding checks payable Proceeds from issuance of short-term debt and lines of credit draws Payments of short-term debt and lines of credit draws Proceeds from issuance of long-term debt, including premium Payment of deferred debt acquisition costs Refinancing and principal payments of long-term debt Net cash and cash equivalents provided by financing activities Increase in cash and cash equivalents (210,796) Liabilities and Net Assets Current liabilities: Accounts payable and accrued expenses Current portion of long-term debt Current portion of operating lease liabilities Current portion of Medicare Advance Payments 364-day Term Loan Other current liabilities $ 453277 26,735 30,348 Consolidated Statements of Operations and Changes in Net Assets Years ended December 31, 2020 and 2019 (Dollars in thousands) 514,254 25,549 33,009 115,915 100,000 143,010 931,737 (1,984,494) 2,055,428 (9,810) (137,315) 6,298 (247,757) 82 (2,428,964) 2,191,389 (4,800) (483,752) 2020 2019 140,636 $ 650,996 76,148 7.063 874 28,633 112,718 1,192 228 16,129 (31,174) ( 302,004 10,070 874 1,812 314,760 Long-term debit Operating lease liabilities Medicare Advance Payments Other liabilities Total liabilities 17,521 (13,858) 325,815 (225,815) 1.148,838 184,043 211,373 399,335 2.875326 205,505 383,010 2,431,739 Net assets without donor restrictions Excess of revenues over expenses Net assets released from restrictions for capital purposes Amortization of unrealized loss on interest rate swap agreement Other Increase in net assets without donor restrictions Net assets with donor restrictions: Contributions Investment return Net assets released from restrictions Other Increase in net assets with donor restrictions Increase in net assets Net assets at beginning of year Net assets at end of year (44,589) Net assets Without donor restriction With donor restriction 382,732 (5,194) (107,012) 255,481 38,708 14,880 19,082 (21,479) (186) 12,297 327,057 25,042 10,567 (15,943) (310) 19,356 132,074 3,047,653 3,179,727 59,074 524,221 2.993,025 186,702 3,179,727 2.880,307 167 346 3,047,653 5.479,392 174.288 135,580 Total net assets Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year 2.720,596 3,047,653 698,509 174,288 Total liabilities and net assets $ 6,055,053